Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
02 October 2014Website:
http://www.calithera.comNext earnings report:
16 July 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Mon, 01 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Calithera Biosciences?
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
What sector is Calithera Biosciences in?
Calithera Biosciences is in the Healthcare sector
What industry is Calithera Biosciences in?
Calithera Biosciences is in the Biotechnology industry
What country is Calithera Biosciences from?
Calithera Biosciences is headquartered in United States
When did Calithera Biosciences go public?
Calithera Biosciences initial public offering (IPO) was on 02 October 2014
What is Calithera Biosciences website?
https://www.calithera.com
Is Calithera Biosciences in the S&P 500?
No, Calithera Biosciences is not included in the S&P 500 index
Is Calithera Biosciences in the NASDAQ 100?
No, Calithera Biosciences is not included in the NASDAQ 100 index
Is Calithera Biosciences in the Dow Jones?
No, Calithera Biosciences is not included in the Dow Jones index
When does Calithera Biosciences report earnings?
The next expected earnings date for Calithera Biosciences is 16 July 2024